Follow
Lap Hing Chi
Lap Hing Chi
FPA Patent Attorneys
Verified email at fpapatents.com - Homepage
Title
Cited by
Cited by
Year
Activation of canonical BMP4-SMAD7 signaling suppresses breast cancer metastasis
BL Eckhardt, Y Cao, AD Redfern, LH Chi, AD Burrows, S Roslan, ...
Cancer research 80 (6), 1304-1315, 2020
492020
Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis
SH Kim, RP Redvers, LH Chi, X Ling, AJ Lucke, RC Reid, DP Fairlie, ...
Disease models & mechanisms 11 (7), DMM034850, 2018
312018
Can preclinical drug development help to predict adverse events in clinical trials?
LH Chi, AD Burrows, RL Anderson
Drug discovery today 27 (1), 257-268, 2022
222022
Bone morphogenetic protein signaling in breast cancer progression
LH Chi, AD Burrows, RL Anderson
Growth Factors 37 (1-2), 12-28, 2019
142019
MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms
LH Chi, RSN Cross, RP Redvers, M Davis, S Hediyeh-Zadeh, ...
Oncogenesis 11 (1), 38, 2022
112022
Abstract PO4-13-10: The anti-metastatic role of BMP4 through cholesterol biosynthesis inhibition and consequent interaction with statin benefit in breast cancer
LH Chi, A Redfern, A Burrows, S Roslan, L Oh, L Spalding, R Anderson
Cancer Research 84 (9_Supplement), PO4-13-10-PO4-13-10, 2024
2024
Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling
LH Chi, AD Redfern, S Roslan, IP Street, AD Burrows, RL Anderson
Cell Communication and Signaling 22 (1), 248, 2024
2024
Mechanisms of BMP4 Regulation of Metastasis
LH Chi
La Trobe, 2022
2022
BMP4 mediated suppression of cholesterol synthesis and breast cancer metastasis
RL Anderson, LH Chi, AD Burrows, S Roslan, A Redfern
Cancer Research 81 (13_Supplement), 2862-2862, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–9